Bayers blood thinner candidate, asundexian, faced a setback in a 2023 clinical trial in which the product failed to demonstrate superiority over competing medications
References Elsevier
Whether youre searching for oral Semaglutide , compounded Semaglutide , or Semaglutide injections near you , RecoveryDelivered.com makes accessing this life-changing treatment easy, affordable, and convenient
In September 2025, the FDA issued a warning letter to Novo Nordisk, the manufacturer of Ozempic, concerning promotional communications that were found to be "false or misleading" because they failed to adequately present the serious risks of these drugs, including their boxed warning for thyroid C-cell tumors and other significant risks like pancreatitis
Regulating FUS liquid-liquid phase separation via specific metal recognition